• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Epicore Biosystems Raises $26M to Advance Sweat-Sensing Wearables

by Fred Pennic 02/10/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
 Epicore Biosystems Raises $26M to Advance Sweat-Sensing Wearables

What You Should Know: 

– Epicore Biosystems, an innovator in sweat-sensing wearables, today announced a $26M in Series B funding round led by the Steele Foundation for Hope (SFFH). 

– The investment will accelerate the global adoption of Epicore’s personalized hydration and cloud analytics platform and support the company’s expansion into new health applications, including kidney health, women’s health, malnutrition, and environmental toxin exposure.

Sweat-Sensing Wearables

Epicore’s technology platform analyzes sweat composition and fluid loss to provide real-time insights into hydration, stress, nutrition, and overall wellness. This non-invasive approach, combined with traditional digital biomarkers, offers a comprehensive view of an individual’s health and can alert users to potential risks such as heat injury, dehydration, and malnutrition.

Addressing Global Health Challenges

Epicore’s technology addresses several critical health challenges, including:

  • Heat-related illness: Excessive heat exposure poses a significant risk to individuals, particularly industrial workers, children, and expecting mothers. Epicore’s wearables can provide real-time alerts to prevent heat injury and dehydration.
  • Malnutrition: The company’s technology can identify early signs of malnutrition, enabling timely intervention and support.
  • Environmental toxin exposure: Epicore is developing solutions to monitor exposure to environmental toxins, helping individuals minimize their risk and protect their health.

Expanding Applications and Partnerships

Since its Series A funding, Epicore has expanded its focus beyond sports and fitness, growing its customer base by 24x with leading multinational enterprises in various sectors. The company’s suite of sweat-sensing solutions includes:

  • Gx Sweat Patch: Commercialized in partnership with PepsiCo and Gatorade for personalized hydration guidance.
  • Discovery Patch® Sweat Collection System: An FDA Class I device for sweat collection and analysis.
  • Connected Hydration wearable and cloud platform: Tailored for industrial workers to monitor hydration and prevent heat-related illness.

“Epicore has developed a new class of biochemical sensing wearables that enable the sports, fitness and connected worker sectors to unlock key health and wellness insights,” said Dr. Roozbeh Ghaffari, CEO and co-founder of Epicore Biosystems. “Our technology delivers data-driven recommendations to the wearer to help manage these types of challenges. The Series B investment will help expand our global reach and accelerate the validation of new biomarkers needed to shape the future of personalized hydration and wellness strategies for all.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |